Oncodesign pursues expansion strategy in North America

French biotech firm Oncodesign (Euronext Paris: ALONC) has announced the creation of a sales and marketing subsidiary based in Cambridge, Oncodesign Biotechnology, near Boston, USA, and the establishment of a joint venture, Synergie MTL, with Mispro Biotech Service, to develop a research facility in Montreal, Canada.

This research facility will increase Oncodesign’s capacity for its experimentation business and puts it in a position to respond more effectively to the needs of its customers in North America by performing their preclinical pharmacology research directly on site, the company said.

Mispro partnership opens new development prospects